Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.16B |
| 2 |
Uber
UBER
|
+$452M |
| 3 |
Analog Devices
ADI
|
+$421M |
| 4 |
Walt Disney
DIS
|
+$376M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.55B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$430M |
| 4 |
NVIDIA
NVDA
|
+$368M |
| 5 |
JPMorgan Chase
JPM
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.78% |
| 2 | Healthcare | 3.27% |
| 3 | Industrials | 2.02% |
| 4 | Financials | 2.02% |
| 5 | Consumer Discretionary | 1.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ACB
3451
Aurora Cannabis
ACB
$233M
| $5.3M | ﹤0.01% |
63,810
+11,553
| +22% | +$842K |
|
|
VNE
3452
DELISTED
Veoneer, Inc.
VNE
| $5.3M | ﹤0.01% |
248,768
+48,699
| +24% | +$922K |
|
3453
Sally Beauty Holdings
SBH
$1.54B
| $5.3M | ﹤0.01% |
406,103
+162,854
| +67% | +$1.74M |
|
3454
PUT
MP Materials
MP
$10.5B
| $5.29M | ﹤0.01% |
164,400
-27,300
| -14% | -$528K |
|
|
DM
3455
CALL
DELISTED
Desktop Metal, Inc.
DM
| $5.29M | ﹤0.01% |
30,750
+21,860
| +246% | +$2.89M |
|
|
VRNT
3456
CALL
DELISTED
Verint Systems
VRNT
| $5.29M | ﹤0.01% |
154,488
-1,374
| -0.9% | -$39K |
|
3457
PUT
GSK
GSK
$99.2B
| $5.28M | ﹤0.01% |
114,720
-8,640
| -7% | -$397K |
|
3458
CALL
Meritage Homes
MTH
$4.76B
| $5.28M | ﹤0.01% |
127,400
+94,000
| +281% | +$4.44M |
|
3459
CALL
SBA Communications
SBAC
$19.6B
| $5.28M | ﹤0.01% |
18,700
-32,500
| -63% | -$9.54M |
|
3460
CALL
Magna International
MGA
$18.8B
| $5.28M | ﹤0.01% |
74,500
+24,600
| +49% | +$1.45M |
|
|
JBTM
3461
JBT Marel
JBTM
$6.23B
| $5.27M | ﹤0.01% |
46,302
+7,426
| +19% | +$766K |
|
3462
CALL
Takeda Pharmaceutical
TAK
$56.3B
| $5.27M | ﹤0.01% |
289,651
-258,549
| -47% | -$4.54M |
|
3463
CALL
Invesco S&P 500 Low Volatility ETF
SPLV
$7.23B
| $5.27M | ﹤0.01% |
93,700
-18,600
| -17% | -$1.02M |
|
|
DM
3464
PUT
DELISTED
Desktop Metal, Inc.
DM
| $5.27M | ﹤0.01% |
30,620
+22,640
| +284% | +$3M |
|
3465
McCormick & Company Non-Voting
MKC
$14.7B
| $5.26M | ﹤0.01% |
+55,010
| New | +$5.19M |
|
3466
ePlus
PLUS
$2.31B
| $5.25M | ﹤0.01% |
119,480
-12,756
| -10% | -$510K |
|
3467
iShares MSCI USA Momentum Factor ETF
MTUM
$26.2B
| $5.25M | ﹤0.01% |
+32,520
| New | +$4.98M |
|
3468
Trip.com Group
TCOM
$28.3B
| $5.24M | ﹤0.01% |
155,400
-290,558
| -65% | -$9.47M |
|
|
WRK
3469
PUT
DELISTED
WestRock Company
WRK
| $5.24M | ﹤0.01% |
120,400
-50,300
| -29% | -$2.08M |
|
3470
Alamos Gold
AGI
$14B
| $5.24M | ﹤0.01% |
598,675
-215,605
| -26% | -$1.91M |
|
|
PHICU
3471
DELISTED
Population Health Investment Co., Inc. Unit
PHICU
| $5.22M | ﹤0.01% |
+500,000
| New | +$5.15M |
|
3472
First Trust Preferred Securities and Income ETF
FPE
$6.34B
| $5.22M | ﹤0.01% |
+258,448
| New | +$5.11M |
|
3473
Innovator US Equity Buffer ETF September
BSEP
$217M
| $5.22M | ﹤0.01% |
179,042
+158,684
| +779% | +$4.44M |
|
3474
Community Health Systems
CYH
$423M
| $5.22M | ﹤0.01% |
702,078
+649,478
| +1,235% | +$4.59M |
|
|
INZY
3475
DELISTED
Inozyme Pharma
INZY
| $5.21M | ﹤0.01% |
252,542
+11,464
| +5% | +$273K |
|
Similar funds
Ken Griffin's Q4 2020 Portfolio in Review
As of Q4 2020, Ken Griffin held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.8% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Ken Griffin opened a new position in S&P Global worth $114M.
- Ken Griffin's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
- Ken Griffin added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
- Ken Griffin fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
- Ken Griffin's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
- Ken Griffin opened 1,988 new positions and closed 1,130 in Q4 2020.
- Ken Griffin's portfolio value rose 9.1% quarter-over-quarter to $385B.
Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.